Catalyst Event
Hangzhou Tigermed Consulting Co Ltd (3347) · Other
From Akros SCHK HK-Global Genomics Index (ASHGGENM)
5/12/2026, 12:00:00 AM
Controlling shareholders, Chairman Mr. Ye Xiaoping and Director Ms. Cao Xiaochun, received a case filing notice from the China Securities Regulatory Commission (CSRC) on May 12, 2026, for an investigation into suspected violations regarding information disclosure of historical shareholding changes. This regulatory action against top management is estimated to have a price impact of ≥10%.
Korean Translation
지배주주인 예샤오핑(Ye Xiaoping) 회장과 카오샤오춘(Cao Xiaochun) 이사가 2026년 5월 12일, 과거 지분 변동 정보 공개 관련 법규 위반 혐의로 중국증권감독관리위원회(CSRC)로부터 입건 통지서를 수령함. 경영진에 대한 조사는 10% 이상의 주가 변동을 초래할 것으로 예상됨.
Related Recent Events
JD Health International Inc (6618) · Earnings Release
Low importance estimated as no market reaction has occurred yet; Q2 2026 earnings report scheduled.
8/12/2026, 12:00:00 AM
Livzon Pharmaceutical Group Inc (1513) · Other
Ex-dividend date on June 16, 2026, for the final dividend of RMB 1.43 per 10 shares, scheduled to be paid on July 13, 2026. Low importance estimated as the dividend amount is within historical norms, scheduled.
6/16/2026, 12:00:00 AM
Grand Pharmaceutical Group Ltd (512) · Other
Ex-dividend date (2026-06-12) for the proposed 2025 final dividend of HK$0.169 per share is scheduled.
6/12/2026, 12:00:00 AM
Veracyte Inc (VCYT) · Other
Annual Meeting of Stockholders on 2026-06-10, with proposals including the election of directors and an expansion of the 2023 Equity Incentive Plan scheduled.
6/10/2026, 12:00:00 AM
Innovent Biologics Inc (1801) · Other
Innovent will present obesity pipeline data at the ADA Scientific Sessions on June 5-8, 2026; this low-impact event is scheduled
6/5/2026, 12:00:00 AM
Pacific Biosciences of California Inc (PACB) · Other
The 2026 Annual Meeting of Stockholders is scheduled for June 3, 2026, including a proposal to increase the number of shares reserved for the 2020 Equity Incentive Plan by 16,000,000. A low impact is estimated due to potential share dilution, scheduled.
6/3/2026, 12:00:00 AM